Neurotrophic factors for the treatment of Parkinson's disease.

Typeset version

 

TY  - 
  - Reviews
  - Sullivan A.M., Toulouse A.
  - 2011
  - June
  - Neurotrophic factors for the treatment of Parkinson's disease.
  - Author
  - Published
  - 0
  - Altmetric: 5 ()
  - Parkinson's disease (PD) is a common neurodegenerative disorder caused by the progressive degeneration of the nigrostriatal dopaminergic pathway. The resulting loss of dopamine neurotransmission is responsible for the symptoms of the disease. Available treatments are initially successful in treating PD symptoms; however, their long-term use is associated with complications and they cannot stop the neurodegeneration. Current research aims at developing new therapies to halt/reverse the neurodegenerative process, rather than treating symptoms. Neurotrophic factors are proteins critical for maintenance and protection of neurones in the developing and adult brain. Several neurotrophic factors have been investigated for their protective effects on dopaminergic neurones. Here we review some of the most promising factors and provide an update on their status in clinical trials.
  - 157
  - 165
  - 10.1016/j.cytogfr.2011.05.001
DA  - 2011/06
ER  - 
@review{V92334129,
   = {Reviews},
   = {Sullivan A.M.,  Toulouse A. },
   = {2011},
   = {June},
   = {Neurotrophic factors for the treatment of Parkinson's disease.},
   = {Author},
   = {Published},
   = {0},
   = {Altmetric: 5 ()},
   = {{Parkinson's disease (PD) is a common neurodegenerative disorder caused by the progressive degeneration of the nigrostriatal dopaminergic pathway. The resulting loss of dopamine neurotransmission is responsible for the symptoms of the disease. Available treatments are initially successful in treating PD symptoms; however, their long-term use is associated with complications and they cannot stop the neurodegeneration. Current research aims at developing new therapies to halt/reverse the neurodegenerative process, rather than treating symptoms. Neurotrophic factors are proteins critical for maintenance and protection of neurones in the developing and adult brain. Several neurotrophic factors have been investigated for their protective effects on dopaminergic neurones. Here we review some of the most promising factors and provide an update on their status in clinical trials.}},
  pages = {157--165},
   = {10.1016/j.cytogfr.2011.05.001},
  source = {IRIS}
}
OTHER_PUB_TYPEReviews
AUTHORSSullivan A.M., Toulouse A.
YEAR2011
MONTHJune
TITLENeurotrophic factors for the treatment of Parkinson's disease.
RESEARCHER_ROLEAuthor
STATUSPublished
PEER_REVIEW0
TIMES_CITEDAltmetric: 5 ()
SEARCH_KEYWORD
REFERENCE
ABSTRACTParkinson's disease (PD) is a common neurodegenerative disorder caused by the progressive degeneration of the nigrostriatal dopaminergic pathway. The resulting loss of dopamine neurotransmission is responsible for the symptoms of the disease. Available treatments are initially successful in treating PD symptoms; however, their long-term use is associated with complications and they cannot stop the neurodegeneration. Current research aims at developing new therapies to halt/reverse the neurodegenerative process, rather than treating symptoms. Neurotrophic factors are proteins critical for maintenance and protection of neurones in the developing and adult brain. Several neurotrophic factors have been investigated for their protective effects on dopaminergic neurones. Here we review some of the most promising factors and provide an update on their status in clinical trials.
PUBLISHER_LOCATION
PUBLISHER
EDITORS
ISBN_ISSN
EDITION
URL
START_PAGE157
END_PAGE165
DOI_LINK10.1016/j.cytogfr.2011.05.001
FUNDING_BODY
GRANT_DETAILS